Spero Therapeutics is trading 5.2% up at $1.22 as the stock stages a technical recovery following several sessions of sharp declines and broader biotech risk-off pressure.
- The move appears to be primarily sentiment-driven as investors reassess recent selling in smaller biotech names.
- There are no fresh company-specific headlines, earnings reports, or regulatory updates tied directly to today's price action.
- The bounce follows a period of significant volatility, suggesting a potential stabilization in investor sentiment.